KATHERINE SCHAUB: Open Payments
NPI 1538686654 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 41 payments from 5 companies in 2025. Trend: 2023 $871 · 2024 $822 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 28 | $495 |
| ViiV Healthcare Company | 7 | $135 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Merck Sharp & Dohme LLC | 3 | $89 |
| Napo Pharmaceuticals Inc | 2 | $36 |
Products named: Yeztugo, ZENPEP, PIFELTRO, CABENUVA, Mytesi, DOVATO, Biktarvy, RUKOBIA.
Industry payments across AZ — which companies pay providers there.
